President Droupadi Murmu has formally launched India’s home-grown gene therapy for cancer — CAR-T cell therapy — at IIT Bombay. India’s first CAR-T cell therapy has been developed in collaboration with IIT Bombay and Tata Memorial Hospital, with industry partner ImmunoACT. This therapy is known for its ability to genetically re-programme the immune system of patients to combat cancer.